World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
71
Citations
44548
World Ranking
19914
National Ranking
9917

Overview

David M. Brown is affiliated with Houston Methodist in the United States. Their research spans the field of Medicine, with a particular focus on Ophthalmology, contributed by 75 publications. Additional subfields include Radiology, Nuclear Medicine and Imaging, Materials Chemistry, Immunology, and Neurology.

The main research topics covered by David M. Brown involve retinal conditions and treatments. These are detailed as:

  • Retinal Diseases and Treatments
  • Retinal Imaging and Analysis
  • Retinal and Optic Conditions
  • Glaucoma and retinal disorders
  • Retinal and Macular Surgery
  • Nanoparticles: synthesis and applications
  • Ocular Diseases and Behçet's Syndrome

Their frequent publication venues include:

  • JAMA Ophthalmology
  • Ophthalmology
  • Ophthalmology Retina
  • The Lancet
  • Eye

Notable recent papers by David M. Brown and co-authors include:

  • Evaluation of Intravitreal Aflibercept for the Treatment of Severe Nonproliferative Diabetic Retinopathy, 2021, JAMA Ophthalmology
  • Long-term Outcomes of Adding Lutein/Zeaxanthin and ω-3 Fatty Acids to the AREDS Supplements on Age-Related Macular Degeneration Progression, 2022, JAMA Ophthalmology
  • Venous overload choroidopathy: A hypothetical framework for central serous chorioretinopathy and allied disorders, 2021, Progress in Retinal and Eye Research
  • Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials, 2023, The Lancet
  • TENAYA and LUCERNE, 2024, Ophthalmology

The scientist has collaborated frequently with the following co-authors:

  • Charles C. Wykoff
  • Jeffrey S. Heier
  • David S. Boyer
  • Justis P. Ehlers
  • Vicki Stone

Best Publications

  • Ranibizumab for Neovascular Age-Related Macular Degeneration

    Philip J. Rosenfeld;David M. Brown;Jeffrey S. Heier;David S. Boyer

  • Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration

    David M. Brown;Peter K. Kaiser;Mark Michels;Gisele Soubrane

  • Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration.

    Jeffrey S. Heier;David M. Brown;Victor Chong;Jean Francois Korobelnik

  • Ranibizumab for Diabetic Macular Edema: Results from 2 Phase III Randomized Trials: RISE and RIDE

    Quan Dong Nguyen;David M. Brown;Dennis M. Marcus;David S. Boyer

  • Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study

    David M. Brown;Mark Michels;Peter K. Kaiser;Jeffrey S. Heier

  • Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis

    E Pisha;H Chai;I S Lee;T E Chagwedera

  • Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study.

    David M. Brown;Peter A. Campochiaro;Rishi P. Singh;Zhengrong Li

  • Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER Study year 1.

    Carl D. Regillo;David M. Brown;Prema Abraham;Huibin Yue

  • Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE.

    David M. Brown;Quan Dong Nguyen;Dennis M. Marcus;David S. Boyer

  • Intravitreal aflibercept for diabetic macular edema.

    Jean François Korobelnik;Diana V. Do;Ursula Schmidt-Erfurth;David S. Boyer

  • Intravitreal Aflibercept Injection for Neovascular Age-related Macular Degeneration: Ninety-Six–Week Results of the VIEW Studies

    Ursula Schmidt-Erfurth;Peter K. Kaiser;Jean François Korobelnik;David M. Brown

  • HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration

    Pravin U Dugel;Adrian Koh;Yuichiro Ogura;Glenn J Jaffe

  • Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema.

    David J Browning;Adam R Glassman;Lloyd Paul Aiello

  • Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III study.

    David M. Brown;Peter A. Campochiaro;Robert B. Bhisitkul;Allen C. Ho

  • Intravitreal Aflibercept for Diabetic Macular Edema: 100-Week Results From the VISTA and VIVID Studies.

    David M. Brown;Ursula Schmidt-Erfurth;Diana V. Do;Frank G. Holz

  • Sustained Delivery Fluocinolone Acetonide Vitreous Inserts Provide Benefit for at Least 3 Years in Patients with Diabetic Macular Edema

    Peter A. Campochiaro;David M. Brown;Andrew Pearson;Sanford Chen

  • ANCHOR STUDY GROUP. RANIBIZUMAB VERSUS VERTEPORFIN FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

    D M Brown;P K Kaiser;M Michels;G Soubrane

  • Successful Bone-Marrow Transplantation for Infantile Malignant Osteopetrosis

    Peter F. Coccia;William Krivit;Jaroslav Cervenka;Carlyle Clawson

  • One-Year Outcomes of the DA VINCI Study of VEGF Trap-Eye in Eyes with Diabetic Macular Edema

    Diana V. Do;Quan Dong Nguyen;David Boyer;Ursula Schmidt-Erfurth

  • RANIBIZUMAB FOR PREDOMINANTLY CLASSIC NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: SUBGROUP ANALYSIS OF FIRST-YEAR ANCHOR RESULTS

    Peter K. Kaiser;David M. Brown;Kang Zhang;Henry L. Hudson

Frequent Co-Authors

Peter K. Kaiser
Peter K. Kaiser Cleveland Clinic
Peter A. Campochiaro
Peter A. Campochiaro Johns Hopkins University School of Medicine
Philip J. Rosenfeld
Philip J. Rosenfeld University of Miami
Mark E. Nesbit
Mark E. Nesbit University of Minnesota
George D. Yancopoulos
George D. Yancopoulos Regeneron (United States)
William Krivit
William Krivit University of Minnesota
Theodore R. Oegema
Theodore R. Oegema Rush University Medical Center
Norma K.C. Ramsay
Norma K.C. Ramsay University of Minnesota
Ursula Schmidt-Erfurth
Ursula Schmidt-Erfurth Medical University of Vienna
Frank G. Holz
Frank G. Holz University of Bonn

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine can open doors to a variety of related fields. For those interested in the business side of healthcare, pursuing a health care administration degree can lead to roles in hospital management, policy, or healthcare consulting. These programs are ideal for individuals eager to impact healthcare systems and patient care quality at a managerial level.

Nurses looking to advance their careers might consider specialized bridge programs. The adn to np bridge programs enable registered nurses with associate degrees to become nurse practitioners faster, expanding their scope of practice and earning potential.

Nutrition also plays a vital role in patient well-being. An online nutrition degree can prepare you for careers in dietetics, wellness coaching, or public health, blending scientific knowledge with practical skills for improving lives.

If you’re already working in healthcare and considering further advancement, finding whats the best online mha program for working adults can be crucial. These flexible, accredited programs allow professionals to earn a Master of Health Administration while balancing work and study.

Best Scientists Citing David M. Brown

Trending Scientists

Recently Published Articles